| Colorectal cancer | Lung cancer | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Univariate | Adjusted; age & deprivation | Univariate | Adjusted; age & deprivation | ||||||||||
Risk difference (95Â % CI) | p-value | Risk difference (95Â % CI) | p-value | Risk difference (95Â % CI) | p-value | Risk difference (95Â % CI) | p-value | ||||||
Patient level | Age | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
65 + yrs | Baseline | Baseline | Baseline | Baseline | |||||||||
45-64Â years | 6.0 | (4.6 to 7.3) | <0.001 | 5.9 | (4.6 to 7.3) | <0.001 | 3.1 | (1.7 to 4.5) | <0.001 | 3.3 | (1.9 to 4.6) | <0.001 | |
15-44 years | 10.3 | (7.1 to 13.4) | <0.001 | 10.1 | (6.9 to 13.3) | <0.001 | 4.2 | (−1.5 to 9.9) | 0.15 | 4.5 | (−1.2 to 10.2) | 0.12 | |
Sex | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | |
Male | Baseline | Baseline | Baseline | Baseline | |||||||||
Female | 0.1 | (−1.1 to 1.4) | 0.82 | 0.0 | (−1.2 to 1.2) | 1.00 | −3.1 | (−4.1 to −2.1) | <0.001 | −3.3 | (−4.3 to −2.3) | <0.001 | |
Ethnicity | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | |
White | Baseline | Â | Baseline | Â | |||||||||
Non-white | 6.7 | (2.7 to 10.7) | 0.001 |  |  |  | −0.7 | (−4.6 to 3.1) | 0.71 |  |  |  | |
Deprivation | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | |
Q1 (least deprived) | Baseline | Baseline | Baseline | Baseline | |||||||||
Q2 | −0.4 | (−2.2 to 1.4) |  | −0.3 | (−2.1 to 1.5) |  | −0.5 | (−2.2 to 1.3) |  | −0.4 | (−2.2 to 1.4) |  | |
Q3 | −0.3 | (−2.2 to 1.5) |  | −0.3 | (−2.1 to 1.6) |  | 0.3 | (−1.4 to 2.1) |  | 0.4 | (−1.3 to 2.1) |  | |
Q4 | 1.0 | (−0.9 to 2.9) |  | 0.9 | (−1.0 to 2.8) |  | −0.3 | (−2.0 to 1.4) |  | −0.4 | (−2.1 to 1.3) |  | |
Q5 (most deprived) | 1.5 | (−0.6 to 3.5) | 0.07 | 1.1 | (−0.9 to 3.1) | 0.14 | −1.0 | (−2.7 to 0.7) | 0.29 | −1.3 | (−3.0 to 0.4) | 0.13 | |
GP demographics | Number of patients per GP | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Q1 (lowest) | Baseline | Baseline | Baseline | Baseline | |||||||||
Q2 | 1.0 | (−0.9 to 2.9) |  | 1.1 | (−0.8 to 3.0) |  | 0.5 | (−1.1 to 2.2) |  | 0.6 | (−1.0 to 2.2) |  | |
Q3 | 1.1 | (−0.9 to 3.1) |  | 1.1 | (−0.9 to 3.1) |  | 0.6 | (−1.0 to 2.3) |  | 0.7 | (−0.9 to 2.3) |  | |
Q4 | 1.6 | (−0.3 to 3.6) |  | 1.5 | (−0.4 to 3.4) |  | 1.7 | (0.1 to 3.3) |  | 1.7 | (0.2 to 3.3) |  | |
Q5 (highest) | 0.4 | (−1.6 to 2.4) | 0.54 | 0.2 | (−1.8 to 2.1) | 0.74 | 2.0 | (0.4 to 3.5) | 0.01 | 1.8 | (0.2 to 3.4) | 0.01 | |
Training practice | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | |
No | Baseline | Baseline | Baseline | Baseline | |||||||||
Yes | 0.2 | (−1.0 to 1.5) | 0.71 | 0.0 | (−1.2 to 1.3) | 0.95 | 0.6 | (−0.5 to 1.6) | 0.27 | 0.6 | (−0.5 to 1.6) | 0.28 | |
GPs aged 50 and over | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | |
Some | Baseline | Baseline | Baseline | Baseline | |||||||||
None | −1.2 | (−3.5 to 1.1) | 0.30 | −1.4 | (−3.6 to 0.9) | 0.24 | −2.6 | (−4.3 to −0.8) | 0.01 | −2.5 | (−4.3 to −0.7) | 0.01 | |
All | 0.9 | (−1.7 to 3.4) | 0.52 | 0.5 | (−2.1 to 3.1) | 0.69 | 2.0 | (−0.1 to 4.1) | 0.07 | 2.0 | (−0.1 to 4.1) | 0.06 | |
GPs female | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | |
Some | Baseline | Baseline | Baseline | Baseline | |||||||||
None | −0.4 | (−2.7 to 1.9) | 0.73 | −0.8 | (−3.1 to 1.6) | 0.53 | 1.3 | (−0.5 to 3.1) | 0.17 | 1.3 | (−0.5 to 3.1) | 0.14 | |
All | −3.0 | (−8.2 to 2.2) | 0.27 | −3.5 | (−8.7 to 1.7) | 0.19 | −4.5 | (−8.4 to −0.6) | 0.03 | −4.6 | (−8.4 to −0.7) | 0.02 | |
GPs qualified in UK | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | |
Some | Baseline | Baseline | Baseline | Baseline | |||||||||
None | −0.1 | (−2.7 to 2.6) | 0.95 | −0.5 | (−3.2 to 2.2) | 0.71 | −0.6 | (−2.6 to 1.5) | 0.59 | −0.5 | (−2.6 to 1.5) | 0.61 | |
All | −0.6 | (−2.0 to 0.7) | 0.35 | −0.4 | (−1.8 to 0.9) | 0.51 | −0.2 | (−1.3 to 0.9) | 0.68 | −0.3 | (−1.4 to 0.8) | 0.61 | |
GP level deprivation | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | |
Q1 (least deprived) | Baseline | Baseline | Baseline | Baseline | |||||||||
Q2 | −1.2 | (−3.1 to 0.7) |  | −1.4 | (−3.3 to 0.6) |  | −1.8 | (−3.5 to −0.1) |  | −1.8 | (−3.5 to −0.1) |  | |
Q3 | −1.0 | (−2.9 to 0.8) |  | −1.3 | (−3.3 to 0.7) |  | −0.3 | (−2.0 to 1.4) |  | −0.6 | (−2.3 to 1.2) |  | |
Q4 | 0.5 | (−1.4 to 2.5) |  | −0.2 | (−2.4 to 1.9) |  | −0.9 | (−2.5 to 0.8) |  | −1.2 | (−3.0 to 0.7) |  | |
Q5 (most deprived) | 0.9 | (−1.2 to 3.0) | 0.17 | −0.4 | (−2.9 to 2.1) | 1.00 | −2.6 | (−4.3 to −0.9) | 0.03 | −2.8 | (−4.8 to −0.8) | 0.04 | |
GP rurality | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | |
Urban > 10 K | Baseline | Baseline | Baseline | Baseline | |||||||||
Town and fringe | −0.7 | (−2.5 to 1.0) | 0.40 | −0.1 | (−1.9 to 1.6) | 0.87 | 0.0 | (−1.5 to 1.5) | 0.96 | −0.2 | (−1.7 to 1.4) | 0.83 | |
Village, hamlet & isolated dwellings | −0.3 | (−3.5 to 2.8) | 0.84 | 0.2 | (−2.9 to 3.3) | 0.90 | 0.7 | (−2.5 to 3.9) | 0.67 | 0.4 | (−2.9 to 3.6) | 0.82 | |
GP general performance | Able to book appointment | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
90Â % and over | Baseline | Baseline | Baseline | Baseline | |||||||||
80-90 % | 0.1 | (−1.2 to 1.4) |  | −0.1 | (−1.4 to 1.2) |  | −0.7 | (−1.7 to 0.4) |  | −0.5 | (−1.6 to 0.6) |  | |
<80 % | 1.1 | (−1.3 to 3.5) | 0.46 | 0.3 | (−2.1 to 2.7) | 0.95 | −0.5 | (−2.4 to 1.4) | 0.32 | −0.3 | (−2.2 to 1.7) | 0.52 | |
Able to see preferred GP | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | |
80Â % and over | Baseline | Baseline | Baseline | Baseline | |||||||||
60-80 % | −0.6 | (−2.0 to 0.9) |  | −0.6 | (−2.1 to 0.8) |  | −1.4 | (−2.6 to −0.2) |  | −1.3 | (−2.5 to 0.0) |  | |
<60 % | 0.5 | (−1.3 to 2.3) | 0.65 | 0.1 | (−1.7 to 1.9) | 0.96 | −1.4 | (−2.8 to 0.0) | 0.05 | −1.2 | (−2.6 to 0.2) | 0.09 | |
Total QOF points | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | |
990 to 1000 (max) points | Baseline | Baseline | Baseline | Baseline | |||||||||
980 to 989 points | 0.1 | (−1.4 to 1.7) |  | 0.0 | (−1.6 to 1.5) |  | −0.8 | (−2.1 to 0.5) |  | −0.7 | (−2.0 to 0.6) |  | |
960 to 979 points | 0.6 | (−1.2 to 2.4) |  | 0.4 | (−1.4 to 2.2) |  | −0.4 | (−1.8 to 1.0) |  | −0.5 | (−1.9 to 0.9) |  | |
<960 points | −0.5 | (−2.5 to 1.4) | 0.93 | −0.9 | (−2.8 to 1.1) | 0.53 | −0.8 | (−2.4 to 0.8) | 0.29 | −0.7 | (−2.3 to 0.9) | 0.65 | |
GP specific cancer activities | Two week wait referral rate | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
Q1 (lowest) | Baseline | Baseline | Baseline | Baseline | |||||||||
Q2 | 0.3 | (−1.6 to 2.3) |  | 0.6 | (−1.3 to 2.5) |  | −1.6 | (−3.2 to −0.1) |  | −1.6 | (−3.2 to −0.1) |  | |
Q3 | −0.6 | (−2.5 to 1.3) |  | −0.3 | (−2.2 to 1.7) |  | −2.3 | (−3.8 to −0.7) |  | −2.3 | (−3.9 to −0.8) |  | |
Q4 | −0.7 | (−2.6 to 1.3) |  | −0.2 | (−2.1 to 1.8) |  | −2.1 | (−3.7 to −0.5) |  | −2.0 | (−3.6 to −0.5) |  | |
Q5 (highest) | −1.2 | (−3.1 to 0.8) | 0.13 | −0.6 | (−2.6 to 1.4) | 0.39 | −3.4 | (−5.0 to −1.8) | <0.001 | −3.3 | (−4.9 to −1.7) | <0.001 | |
Two week wait conversion | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | |
Q1 (lowest) | Baseline | Baseline | Baseline | Baseline | |||||||||
Q2 | 0.8 | (−1.2 to 2.7) |  | 1.0 | (−1.0 to 3.0) |  | 1.3 | (−0.3 to 3.0) |  | 1.5 | (−0.1 to 3.1) |  | |
Q3 | −2.5 | (−4.5 to −0.5) |  | −2.0 | (−4.0 to −0.1) |  | 1.2 | (−0.4 to 2.9) |  | 1.3 | (−0.4 to 2.9) |  | |
Q4 | −1.8 | (−3.7 to 0.2) |  | −1.3 | (−3.2 to 0.7) |  | 3.6 | (2.0 to 5.2) |  | 3.6 | (2.0 to 5.2) |  | |
Q5 (highest) | 0.6 | (−1.3 to 2.6) | 0.56 | 1.2 | (−0.7 to 3.1) | 0.96 | 4.1 | (2.5 to 5.7) | <0.001 | 4.0 | (2.4 to 5.6) | <0.001 | |
Two week wait detection | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | |
Q1 (lowest) | Baseline | Baseline | Baseline | Baseline | |||||||||
Q2 | 1.5 | (−0.5 to 3.4) |  | 1.7 | (−0.2 to 3.7) |  | −1.1 | (−2.7 to 0.5) |  | −1.1 | (−2.6 to 0.5) |  | |
Q3 | 0.7 | (−1.2 to 2.6) |  | 0.9 | (−0.9 to 2.8) |  | −1.0 | (−2.5 to 0.6) |  | −0.8 | (−2.4 to 0.7) |  | |
Q4 | −1.2 | (−3.3 to 0.9) |  | −0.8 | (−2.9 to 1.2) |  | −0.7 | (−2.3 to 0.9) |  | −0.6 | (−2.2 to 1.1) |  | |
Q5 (highest) | 1.3 | (−0.6 to 3.3) | 0.92 | 1.6 | (−0.4 to 3.5) | 0.72 | −1.3 | (−2.9 to 0.3) | 0.22 | −1.3 | (−2.9 to 0.3) | 0.23 | |
GP other activities | Average colonoscopy, sigmoidoscopy and upper GI endoscopy | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â |
T1 (lowest) | Baseline | Baseline | Baseline | Baseline | |||||||||
T2 | −0.3 | (−1.8 to 1.2) |  | 0.0 | (−1.5 to 1.5) |  | −1.1 | (−2.4 to 0.1) |  | −1.1 | (−2.3 to 0.2) |  | |
T3 (highest) | −2.4 | (−3.9 to −0.9) | 0.002 | −2.0 | (−3.5 to −0.5) | 0.01 | −0.7 | (−2.0 to 0.5) | 0.27 | −0.5 | (−1.7 to 0.8) | 0.48 | |
Emergency admissions | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | Â | |
Q1 (lowest) | Baseline | Baseline | Baseline | Baseline | |||||||||
Q2 | −0.2 | (−2.1 to 1.8) |  | 0.2 | (−1.8 to 2.1) |  | 0.4 | (−1.3 to 2.0) |  | 0.4 | (−1.2 to 2.1) |  | |
Q3 | −0.7 | (−2.6 to 1.3) |  | −0.3 | (−2.2 to 1.7) |  | 1.0 | (−0.6 to 2.7) |  | 1.0 | (−0.6 to 2.7) |  | |
Q4 | −0.7 | (−2.7 to 1.3) |  | −0.2 | (−2.2 to 1.7) |  | 0.8 | (−0.8 to 2.3) |  | 0.9 | (−0.7 to 2.5) |  | |
Q5 (highest) | −0.9 | (−2.8 to 1.1) | 0.32 | −0.3 | (−2.2 to 1.7) | 0.66 | 1.3 | (−0.3 to 2.9) | 0.10 | 1.6 | (0.0 to 3.2) | 0.04 |